MSD

Bovilis® INtranasal RSP™Live is a live, intranasal vaccine for cattle that protects against two important respiratory viruses, RSV and PI3. Presentation A lyophilisate and solvent for suspension Active ingredients Each dose (2 ml) contains: Bovine Respiratory Syncytial Virus (BRSV) Live bovine parainfluenza virus type 3 (PI3)

For the active immunisation of cattle against • Parainfluenza3 virus (PI3 virus), to reduce infections. • Bovine Respiratory Syncytial Virus (BRSV) to reduce infection and clinical signs. • Mannheimia (Pasteurella) haemolytica serotype A1, to reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung caused by serotypes A1 and A6. Cross-reactive immunity to the A6 serotype of M. haemolytica has been demonstrated in a challenge experiment under laboratory conditions after a primary course of vaccination. Approximately two weeks after completion of the basic immunisation programme, the humoral immune response against BRS-Virus and PI3-Virus is at its highest level. The duration of protective immunity has not been established in challenge experiments. Dosage & Administration: Vaccination dose: 5 ml by subcutaneous injection at the side of the neck.

For the active immunisation of cattle in order to induce serological and colostral antibody production against Salmonella dublin and Salmonella typhimurium and in the face of an outbreak to reduce Salmonella typhimurium infections when used under field conditions as part of an overall herd management programme. Bovivac S may also contribute to reducing S. typhimurium contamination of the environment. Dosage & Administration • Calves up to 6 months of age - 2 ml • Adult cattle - 5 ml

Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs. For uses, dosage, contra-indications and warnings please consult your veterinary practitioner or the Summary of Product Characteristics (SPC). Further information is available on request. Use medicines responsibly. Last up 12 weeks. The following tablet strengths are: Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg) Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg) Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg) Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg) Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).

Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs. For uses, dosage, contra-indications and warnings please consult your veterinary practitioner or the Summary of Product Characteristics (SPC). Further information is available on request. Use medicines responsibly. Last up 12 weeks. The following tablet strengths are: Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg) Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg) Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg) Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg) Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).

Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs. For uses, dosage, contra-indications and warnings please consult your veterinary practitioner or the Summary of Product Characteristics (SPC). Further information is available on request. Use medicines responsibly. Last up 12 weeks. The following tablet strengths are: Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg) Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg) Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg) Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg) Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).